Incidence, clinical spectrum, and immunotherapy of non-ischemic cerebral enhancing lesions after endovascular therapy.

Antonios BayasMonika ChristAnsgar BerlisMarkus NaumannMichael ErtlFelix JoachimskiMona MüllerJulia WelzelLisa Ann GerdesKlaus SeelosChristoph Maurer

Published in: Therapeutic advances in neurological disorders (2022)

Delayed NICE lesions are a rare complication after EVT, requiring immunotherapies in all patients reported here. Physicians should be aware of this disorder in case of new symptoms or contrast enhancing lesions after EVT.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
primary care
peritoneal dialysis
stem cells
magnetic resonance imaging
cerebral ischemia
depressive symptoms
blood brain barrier